Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT00397904
Status:
COMPLETED
Last Update Posted:
2015-11-25
First Post:
2006-11-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-09
First Submit QC Date:
None
Study First Post Date:
2006-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-22
Results First Submit QC Date:
None
Results First Post Date:
2015-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-22
Last Update Post Date:
2015-11-25
Last Update Post Date Type:
ESTIMATED